Overview
- RKI estimates about 7.1 million acute respiratory infections in the past week, with COVID‑19 at roughly 500 cases per 100,000 and few severe cases reported so far.
- Omicron lineage XFG (Stratus) made up about 82% of sequences from mid‑August to mid‑September, and RKI and WHO currently see no increased public‑health risk.
- STIKO advises COVID‑19 booster doses and influenza vaccination this autumn for people aged 60 and older as well as adults with underlying conditions.
- STIKO recommends a one‑time RSV vaccine for everyone 75 and over and for 60–74‑year‑olds with severe comorbidities, preferably before the October–March RSV season.
- Newborns and infants are offered the monoclonal antibody nirsevimab for their first RSV season, and PCR testing is preferred when clinical decisions hinge on identifying the specific virus.